Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA4 | P22748 | 4/20 | 0.35 |
| ▸ | CA9 | Q16790 | 4/20 | 0.35 |
| ▸ | FPR2 | P25090 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.30 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11077242 | 0.87 | L3MBTL1 (0.37) | L3MBTL1CA1CA2CA4CA9 | |
| SCHEMBL28435066 | 0.82 | L3MBTL1 (0.33) | L3MBTL1CA1CA2CA4CA9 | |
| SCHEMBL3834096 | 0.79 | TDP1 (0.35) | L3MBTL1CA1CA2CA4CA9 | |
| SCHEMBL6425453 | 0.79 | L3MBTL1 (0.38) | L3MBTL1 | |
| SCHEMBL19719415 | 0.78 | TSHR (0.36) | L3MBTL1 | |
| SCHEMBL19448264 | 0.78 | TSHR (0.36) | L3MBTL1 | |
| SCHEMBL19719451 | 0.78 | TSHR (0.36) | L3MBTL1 | |
| SCHEMBL9844016 | 0.78 | MITF (0.55) | L3MBTL1CA1CA2CA4CA9 | |
| SCHEMBL6645271 | 0.78 | TAAR1 (0.41) | L3MBTL1TDP1 | |
| SCHEMBL8777407 | 0.75 | CA1 (0.33) | L3MBTL1CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116096719-A | Pyridazinylamino derivatives as ALK5 inhibitors | 奇斯药制品公司 | 2023-05-09 | — | — | CN | disclosed |